Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H24Cl2N10 |
| Molecular Weight | 475.378 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(NC(=N)NC(=N)N2CCN(CC2)C(=N)NC(=N)NC3=CC=C(Cl)C=C3)C=C1
InChI
InChIKey=YNCLPFSAZFGQCD-UHFFFAOYSA-N
InChI=1S/C20H24Cl2N10/c21-13-1-5-15(6-2-13)27-17(23)29-19(25)31-9-11-32(12-10-31)20(26)30-18(24)28-16-7-3-14(22)4-8-16/h1-8H,9-12H2,(H4,23,25,27,29)(H4,24,26,28,30)
Picloxydine is a heterocyclic biguanide with antibacterial and antiplaque activity. 0.4% Picloxydine produces a highly significant drop in the number of aerobic organisms. 0.4% Picloxydine is far more effective than 0.2% Picloxydine or chlorhexidine in reducing the total viable count of oral aerobic and anaerobic organisms. It is used to treat superficial eye infections. Picloxydine is also used in eye drops in the topical therapy of trachoma. This drug can cause side effects - local intolerance reactions (temporary irritation, allergic reactions).
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
S01AX16
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
||
|
WHO-VATC |
QS01AX16
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
227-084-3
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
4YC2PY3AEU
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
SUB09813MIG
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
71663
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
3467
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
100000081938
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
1519
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
C72645
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
PICLOXYDINE
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
DTXSID50863586
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
5636-92-0
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
C005253
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
DB13607
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104722
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | |||
|
m8780
Created by
admin on Mon Mar 31 18:02:11 GMT 2025 , Edited by admin on Mon Mar 31 18:02:11 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY
